November continues its equity market mudslide this morning, as trepidation grips the market ahead of two important releases later this week: NVIDIA's ( NVDA ) earnings report after the bell tomorrow and the Employment Situation report for September (still lagging, but better than nothing). Until one or both of these brings a sigh of relief to market participants, we'll likely see a “risk-off” trading environment.

Lockheed Martin expands Black Hawk capabilities with MATRIX autonomy and the new U-Hawk to advance multi-mission rotorcraft operations.

OPEN stock surges 889% as its AI-first Opendoor 2.0 rebuild slashes costs, speeds up deals and aims to reshape iBuying economics.

COF's NII momentum holds strong as credit card demand, funding mix gains and the Discover deal support growth despite rate cuts.

Burlington, Massachusetts--(Newsfile Corp. - November 18, 2025) - Lifordi Immunotherapeutics, Inc., a clinical-stage biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, today announced a strategic investment from Sanofi Ventures, the venture arm of global healthcare leader Sanofi, and funding from existing investors ARCH Ventures, 5AM Ventures, and Atlas Venture. The new funds bring the total raised to $112 million and support an ongoing Phase 1 study in Rheumatoid Arthritis (RA) designed to evaluate LFD-200, an ADC delivering a potent glucocorticoid (GC) directly to immune cells.

Power Solutions International (PSIX) delivered record Q3 2025 revenue of $203.9 million, driven by surging demand in its power system segment. Despite strong topline growth, PSIX faced margin pressure in the last quarter. However, this weakness appears temporary and is expected to recover as volume expands in high-growth end markets. Structural tailwinds from AI infrastructure and data center expansion position PSIX for sustained double-digit growth, with capacity investments supporting future volume increases.

The Western Union Company ( WU ) J.P. Morgan 2025 Ultimate Services Investor Conference November 18, 2025 9:40 AM EST Company Participants Devin McGranahan - President, CEO & Director Conference Call Participants Tien-Tsin Huang - JPMorgan Chase & Co, Research Division Presentation Tien-Tsin Huang JPMorgan Chase & Co, Research Division All right.

NIQ Global Intelligence plc ( NIQ ) J.P. Morgan 2025 Ultimate Services Investor Conference November 18, 2025 10:20 AM EST Company Participants James Peck - CEO & Chairman Michael Burwell - Chief Financial Officer Conference Call Participants Alexander EM Hess - JPMorgan Chase & Co, Research Division Presentation Alexander EM Hess JPMorgan Chase & Co, Research Division This is Alex Hess covering for services, information services data book, our quarterly firm is up here.

Waters Corporation ( WAT ) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM EST Company Participants Udit Batra - President, CEO & Director Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Presentation Tycho Peterson Jefferies LLC, Research Division Okay. Thank you, everybody.

UPST's expanding push into auto, home, and small-dollar lending gains traction as new products scale and funding partners grow.

DB outlines a 2028 plan targeting RoTE above 13% while driving revenue growth, tighter costs, and stronger capital discipline.

VTR's expanding SHOP footprint, rising cash NOI and active capital recycling underscore its growth momentum.

Archer Aviation's sharp share surge, new tech deals and bold expansion moves raise big questions about whether its momentum can last.

The shares of Honeywell International Inc (NASDAQ:HON) are lower this morning after a rare double downgrade to "sell" from "buy" at BofA Global Research.

HD's Q3 results are affected due to missing storm-driven demand, consumer uncertainty, and housing-market pressures limiting sales momentum.

COLB lifts its quarterly dividend by 2.8% as decent liquidity supports ongoing shareholder rewards.

Arbe Robotics Ltd. remains a Sell due to minimal revenue, persistent losses, and a long path to commercial scale despite promising technology. ARBE stock's valuation is extremely high, with revenue and profitability metrics far below sector averages, relying solely on a distant growth story. Management expects key OEM design wins and non-automotive revenue growth, but meaningful auto revenue likely won't arrive until 2027-2028.

First Advantage Corporation ( FA ) J.P. Morgan 2025 Ultimate Services Investor Conference November 18, 2025 9:00 AM EST Company Participants Steven Marks - Executive VP & CFO Conference Call Participants Alexander EM Hess - JPMorgan Chase & Co, Research Division Presentation Alexander EM Hess JPMorgan Chase & Co, Research Division Good morning.

C3is Inc. ( CISS ) Q3 2025 Earnings Call November 18, 2025 10:00 AM EST Company Participants Diamantis Andriotis - CEO, President & Director Nina Pyndiah - Chief Financial Officer Presentation Operator Good day, and thank you for standing by. Welcome to the C3is Third Quarter 2025 Financial and Operating Results Conference Call.

Medtronic plc ( MDT ) Q2 2026 Earnings Call November 18, 2025 8:00 AM EST Company Participants Ryan Weispfenning - VP & Head of Investor Relations Geoffrey Martha - Chairman of the Board & CEO Thierry Pieton - Executive VP & CFO Laura Mauri - Senior VP and Chief Scientific & Medical Officer Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Travis Steed - BofA Securities, Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Shagun Singh Chadha …